Free Trial

Abivax (ABVX) Earnings Date, Estimates & Call Transcripts

Abivax logo
$129.73 -2.90 (-2.19%)
As of 03:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Abivax Earnings Summary

Abivax announced Q1 2026 earnings on May 22, 2026, reporting an EPS of -$0.71, which beat the consensus estimate of -$0.94 by $0.23. Quarterly revenue was reported to be $1.56 million, above analysts' expectations of $0.40 million. With a trailing EPS of -$5.21, Abivax's earnings are expected to grow next year, from ($3.27) to ($2.86) per share.

Latest Q1
Earnings Date
May. 22Estimated
Consensus EPS
(May. 22)
-$0.94
Actual EPS
(May. 22)
-$0.71 Beat By $0.23
Actual Revenue
(May. 22)
$1.56M

Q1 2026 Earnings Resources

Get Abivax Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abivax and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ABVX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ABVX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Abivax Analyst EPS Estimates

Current Year EPS Consensus Estimate
($3.27) EPS
Next Year EPS Consensus Estimate
($2.86) EPS

Abivax Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/22/2026Q1 2026-$0.9359-$0.71+$0.2259-$0.71$0.40M$1.56M
3/23/2026Q4 2025-$2.24-$1.20+$1.04-$1.20$1.80M$0.52M
2/14/2026Q4 2025--$1.20--$1.20-$0.52M
12/15/2025Q3 2025--$2.46--$2.46--$4.92M
9/8/2025Q2 2025-$0.90-$0.86+$0.04-$0.86$1.35M-

Data powered by Fiscal.ai.

Abivax Earnings - Frequently Asked Questions

Abivax (NASDAQ:ABVX) last announced its quarterly earning data on Friday, May 22, 2026. Learn more on ABVX's earnings history.

In the previous quarter, Abivax (NASDAQ:ABVX) reported ($0.71) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.94) by $0.23. Learn more on analysts' earnings estimate vs. ABVX's actual earnings.

Abivax (NASDAQ:ABVX) has a recorded net income of -$380.27 million. ABVX has generated -$5.21 earnings per share over the last four quarters.

Abivax's earnings are expected to grow from ($3.27) per share to ($2.86) per share in the next year.


This page (NASDAQ:ABVX) was last updated on 6/1/2026 by MarketBeat.com Staff.
From Our Partners